Prognostic significance of PCNA expression in laryngeal cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 12, 1998, Pages 1321-1324

  Saraç, Sarp ^a,b   Ayhan, Ayse ^a   Hosal, A Sefik ^a   Kaya, Sefa ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Mesa Camyolu Sitesi C2B D:19 ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NECK DISSECTION; PROGNOSIS;

EID: 0031675879     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.12.1321     Document Type: Article

References (25)

1. Broders AC. Carcinoma. Arch Pathol. 1926;2:376-381.
2. Cells JE, Cells A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A. 1985;82:3262-3266.
3. Ayhan A, Yasui W, Yokazaki H, Kitada Y, Tahara E. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastasis in human colorectal carcinomas. Virchows Arch B Cell Pathol. 1993;63:213-218.
4. American Joint Committee on Cancer. Manual for Staging Cancer. 4th ed. Philadelphia, Pa: JB Lippincott; 1992.
5. Pera E, Moreno A, Galdino L. Prognostic factors in laryngeal carcinoma. Cancer. 1986;58:928-934
6. Kashima HK. The characteristics of laryngeal cancer correlating with cervical lymph node metastasis. In: Alberti PW, Bryce DP, eds. Workshops From the Centennial Conference on Laryngeal Cancer. East Norwalk. Conn: Appleton-Century-Crofts; 1976:855-861.
7. McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer. 1961;14:55-66.
8. Poleksic S, Kalwaic HJ. Prognostic value of vascular invasion in squamous cell carcinoma of the head and neck. Plast Reconstr Surg. 1978;61:234-240.
9. Norris CM, Tucker GF Jr, Kuo BF, Pitser WF. A correlation of clinical staging, pathological findings and five year end results in surgically treated cancer of the larynx. Ann Otol Rhinol Laryngol. 1970;79:1033-1048.
10. Thompson AC, Bradley PJ, Griffin NR. Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am J Surg. 1994;168:469-471.
11. Underwood JCE. Lymphoreticular infiltration in human tumors: prognostic and biologic implications. Br J Cancer. 1974;30:538-548.
12. Klemi PJ, Alanen K, Jalkanen S, Joensuu H. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma. Br J Cancer. 1992;66:739-743.
13. Jain S, Filipe MI, Hall PA, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol. 1991;44:655-659.
14. Tahan SR, Neuberg DS, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer. 1993;71:3552-3559.
15. Hartmann LC, Sebo TJ, Kamel NA, et al. Proliferating cell nuclear antigen in epithelial ovarian cancer. Gynecol Oncol. 1992;47:191-195.
16. Pich A, Chiusa L, Pisani P, Krengli M, Pia F, Navone R. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J Cancer Res Clin Oncol. 1992;119:106-110.
17. Lipponen PK, Eskelinen MJ. Cell proliferation of transitional cell bladder tumour determined by PCNA/cyclin immunostaining and its prognostic significance. Br J Cancer. 1992;66:171-176.
18. Oka K, Hoshi T, Arai T. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation alone. Cancer. 1992;70:1545-1550.
19. Munck-Wikland E, Fernberg JO, Kuylenstierna R, Lindholm J, Auer G. Proliferating cell nuclear antigen (PCNA) expression and nuclear DNA content in predicting recurrence after radiotherapy of early glottic cancer. Eur J Cancer B Oral Oncol. 1993;298:75-79.
20. Tsuji T, Sasaki K, Kimura Y, Yamada K, Mori M, Shinozaki F. Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers. Int J Oral Maxillofac Surg. 1992;21:369-372.
21. Munck-Wikland E, Edstrom S, Jungmark E, Kuylenstierna R, Lindholm J, Auer G. Nuclear DNA content, proliferating cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer. 1994;56:95-99.
22. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol. 1995;104:503-510.
23. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst. 1993;85:971-978.
24. Fidler IJ, Hart IR. Biologic diversity in metastatic neoplasms: origins and implications. Science. 1982;217:998-1004.
25. Fidler IJ, Kripke ML. Metastatic results from pre-existing variant cells within a malignant tumor. Science. 1977;197:893-898.